During vaginal sex, HIV can pass from a female partner to a male partner when infected vaginal fluid or blood comes into contact with vulnerable tissue on the penis. The estimated risk per act of unprotected vaginal sex is about 0.04%, or roughly 1 in 2,380. That number is low on a per-encounter basis, but it’s not zero, and several common factors can push it significantly higher.
How the Virus Enters the Male Body
HIV needs a route from infected fluid into the bloodstream. During vaginal intercourse, the penis is exposed to vaginal fluid and sometimes blood, both of which can carry the virus in significant concentrations. The CDC identifies three main entry points on the penis: the urethral opening at the tip, the foreskin (in uncircumcised men), and any cuts, sores, or micro-abrasions on the shaft or head.
The foreskin is particularly susceptible because its inner surface contains a high density of immune cells that HIV targets. These cells sit close to the skin’s surface, giving the virus easier access. The urethra is lined with mucous membrane rather than tougher external skin, which also makes it more permeable to the virus. Even without visible injuries, microscopic tears from the friction of sex can create additional pathways.
What the 1-in-2,380 Risk Actually Means
A 0.04% per-act risk sounds reassuringly small, but it’s important to understand what that figure represents. It’s an average across all encounters, all viral loads, and all conditions. Your actual risk during any single encounter could be much higher or effectively zero depending on the circumstances. Over repeated exposures with the same partner, cumulative risk climbs. Ten unprotected encounters with an untreated partner don’t carry a 0.04% risk; they carry roughly a 0.4% combined probability, and that number keeps rising with each additional exposure.
The risk also isn’t evenly distributed. Most transmissions likely happen when specific amplifying factors are present, meaning any individual encounter could carry far more risk than the average suggests.
Factors That Increase the Risk
Other Sexually Transmitted Infections
Having another STI is one of the strongest risk multipliers for HIV transmission in both directions. Infections like chlamydia and gonorrhea cause inflammation, which recruits exactly the type of immune cells HIV likes to infect and concentrates them near the surface of genital tissue. Ulcerative infections like syphilis and herpes create open sores that bypass the skin barrier entirely, giving HIV a direct path into the bloodstream. An untreated STI in either partner increases risk substantially.
High Viral Load
The amount of virus in the female partner’s blood and genital fluids is the single most important variable. Viral load is highest in the weeks immediately after a new infection, often before the person knows they have HIV. It’s also high when someone isn’t on treatment or isn’t taking medication consistently. Higher viral load means more virus in vaginal fluid, which means a greater chance of transmission with each exposure.
Breaks in the Skin
Any irritation, cut, or sore on the penis increases vulnerability. This includes friction-related micro-tears, skin conditions like eczema, and trauma from rough sex. Even small abrasions that aren’t visible to the naked eye can be enough.
Menstruation
Blood carries a higher concentration of HIV than vaginal fluid alone. Sex during menstruation exposes the male partner to more of the virus, raising the per-act risk above the average estimate.
Circumcision Lowers Risk by About 60%
Three large randomized controlled trials found that male circumcision reduces the risk of acquiring HIV through vaginal sex by approximately 60%. The World Health Organization endorsed circumcision as a prevention strategy based on this evidence. The protective effect comes from removing the foreskin, which contains the vulnerable immune cells and thin mucosal tissue that HIV exploits. Circumcision doesn’t eliminate risk, but it meaningfully reduces it. This finding applies specifically to female-to-male vaginal transmission.
When the Risk Drops to Zero
A person living with HIV who takes antiretroviral therapy and maintains an undetectable viral load has zero risk of transmitting the virus to sexual partners. This isn’t a theoretical estimate. Large studies tracking thousands of couples where one partner was HIV-positive and on effective treatment recorded no transmissions when viral load was undetectable. The CDC states this plainly: undetectable means untransmittable. This applies to vaginal sex, anal sex, and sex without condoms.
“Undetectable” means the amount of virus in the blood is so low that standard lab tests can’t measure it, typically below 200 copies per milliliter. Reaching this level usually takes a few months after starting treatment, and it requires taking medication consistently.
Prevention Options for Men at Risk
Condoms remain the most accessible barrier method. Used consistently and correctly, they block the contact between vaginal fluid and penile tissue that transmission depends on.
PrEP (pre-exposure prophylaxis) is a daily medication for HIV-negative people that dramatically reduces the chance of infection. While specific effectiveness data for insertive vaginal sex hasn’t been isolated in studies, PrEP is widely prescribed and recommended for men with ongoing exposure risk through heterosexual contact.
If you’ve already had a potential exposure, PEP (post-exposure prophylaxis) is a 28-day course of HIV medication that can prevent infection if started within 72 hours. The sooner it’s started, the more effective it is. After the 72-hour window, PEP is unlikely to work.
When and How to Test
No HIV test can detect the virus immediately after exposure. There’s a window period during which the virus is present in the body but hasn’t produced enough markers for a test to pick up. The most common lab test, which detects both viral proteins and antibodies from a blood draw, can usually identify HIV between 18 and 45 days after exposure. A negative result at 45 days is highly reliable for most people, though the exact window depends on the type of test used.
Rapid tests done with a finger prick or oral swab have a longer window period than lab-based blood tests. If you’re testing after a specific exposure, a lab-based blood draw will give you an accurate answer sooner. Testing too early can produce a false negative, so timing matters.